Zhi Liang
79 Qingchun Road
Hangzhou, 310003, China
Hangzhou, 310003, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Tolerogenic dendritic cells induced by withdrawal of polyunsaturated fatty acid DHA and mTOR inhibitor PP242 attenuate allograft rejection.
Journal: Acta biochimica et biophysica Sinica
Published: February 27, 2026
USP44 Stabilizes MAOB via Deubiquitination to Inhibit Cisplatin Resistance in Lung Adenocarcinoma.
Journal: International journal of genomics
Published: December 05, 2025
Engineering Immunoregenerative Therapy via an Immunomodulatory Binary Pharmacology Hydrogel Depot for Prolonged Allograft Survival.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: October 21, 2025
Macrophage-delivered Nifuroxazide reprograms immunosuppressive microenvironment and synergizes with oxaliplatin for enhanced anti-hepatocellular carcinoma therapy.
Journal: Journal of nanobiotechnology
Published: October 02, 2025
Development and Validation of a Predictive Nomogram for Early Postoperative Recurrence in Non-Small Cell Lung Cancer.
Journal: Medical science monitor : international medical journal of experimental and clinical research
Published: July 13, 2025
Artesunate-mycophenolate Mofetil Dimer Micelles Alleviate Allogeneic Skin Graft Rejection by Inhibiting the TLR-4 Pathway in Macrophages.
Journal: Theranostics
Published: December 04, 2024
Advancing immunomodulation in organ transplantation: the therapeutic potential of self-assembled rapamycin nanoparticles in allograft rejection.
Journal: Journal of nanobiotechnology
Published: October 16, 2024
LncRNA FEZF1-AS1 facilitates cisplatin resistance in non-small cell lung cancer through modulating the miR-32-5p-glutaminase axis.
Journal: American journal of cancer research
Published: March 15, 2024
Carvacrol ameliorates skin allograft rejection through modulating macrophage polarization by activating the Wnt signalling pathway.
Journal: Phytotherapy research : PTR
Published: December 11, 2023
Chemically engineered mTOR-nanoparticle blockers enhance antitumour efficacy.
Journal: EBioMedicine
Published: August 30, 2023
RapaLink-1 outperforms rapamycin in alleviating allogeneic graft rejection by inhibiting the mTORC1-4E-BP1 pathway in mice.
Journal: International immunopharmacology
Published: August 18, 2023
Showing 1-11 of 11
Last Updated: 09/26/2026